Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Health

Researchers test new type of TMPRSS2 inhibitors for inhibiting COVID-19 infection

Staff Writer
Staff Writer 7 months ago
Updated 2021/10/13 at 1:12 AM
Share
SHARE

On a path to better understanding the mechanisms of viral pathogenesis, a research team at Washington University in St. Louis were able to construct a chemical compound they believe can interfere with the virus’ invasion of human cells for prolonged infection.

Known as MM3122, the findings in Proceedings of the National Academy of Sciences show that the compound may in fact provide beneficial effects when it comes to preventing infection and decreasing the severity of symptoms associated with viral diseases, like SARS-CoV-2.

The compound is said to work by targeting and inhibiting the protein transmembrane serine protease 2 (TMPRSS2), used by coronaviruses to thrive by infecting human cells. The compound also inhibits the protein matriptase.

“MM3122 represents an advanced lead candidate for clinical development as a novel antiviral drug for COVID-19,” the study’s authors explained in their PNAS report. “In addition to being novel drugs, these selective TMRSS2 inhibitors can be used as valuable chemical probes to help elucidate mechanisms of viral pathogenesis.”

“Since TMPRSS2 plays a key role as a viral protein processing protease in the pathogenesis of other coronaviruses (SARS-CoV, MERS-CoV) as well as influenza viruses, MM3122 and this class of TMPRSS2 inhibitors hold much promise as new drugs to not only treat SARS-CoV-2 infections but also potentially represent broad-spectrum antivirals.”

You Might Also Like

New research claims COVID-19 contagion may raise the risk of neurodegenerative disorder

New research of vegetarian diets uncovered similar growth and nutrition as meat consumers

Being overweight during childhood may raise the risk of type 1 diabetes

Over a million less smokers projected after U.S. ban on menthol cigarettes: study

Study probes the communication between physicians and patients regarding e-cigarette use

TAGGED: COVID-19, matriptase, SARS-CoV-2, TMPRSS2
Staff Writer October 12, 2021
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Merck seeks FDA authorization for antiviral drug treatment molnupiravir
Next Article Study suggests neurosteroid replacement therapy may effectively treat postpartum depression

Recommended

Clinical

New research claims COVID-19 contagion may raise the risk of neurodegenerative disorder

1 Min Read
Health

New research of vegetarian diets uncovered similar growth and nutrition as meat consumers

1 Min Read
Health

Being overweight during childhood may raise the risk of type 1 diabetes

1 Min Read
Health

Over a million less smokers projected after U.S. ban on menthol cigarettes: study

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?